Cardiology Partners

Cardiology Partners is a comprehensive cardiovascular care provider based in South Florida, offering a full spectrum of diagnostic, therapeutic, and interventional services. Founded in 1984, the company operates a network of clinics and a specialized research arm, the Cardiology Partners Clinical Research Institute, which serves as a site for Phase 2 and Phase 3 clinical trials for major pharmaceutical companies such as Novartis, Bayer, and Boehringer Ingelheim. In July 2025, the practice was acquired by Cardiovascular Associates of America (CVAUSA), a private equity-backed network of cardiovascular specialists. The company is recognized for its expertise in managing complex conditions such as heart failure, hypertension, and peripheral vascular disease, utilizing advanced technologies like nuclear cardiac stress testing and cardiac catheterization.